MD, PhD
Centro Hospitalar Universitário de Santo António (CHUdSA)
Hospital Santo António (HSA)
Research group
Autoimmunity & Neurosciences
Carlos Vasconcelos was born in Portugal 27/03/1952, qualified MD in 1976 by Universidade do Porto, Portugal and in 1987 became Internal Medicine Specialist, with differentiation in the field of Clinical Immunology: autoimmune diseases and primary and HIV associated immunodeficiency’s.
In 1992, worked with Prof. Yehuda Shoenfeld in the TelAviv University, in the areas of immunology and rheumatology.
He received his PhD in 2007 with the thesis “Epidemiology of Systemic Lupus Erythematosus in the north of Portugal”.
He was the founder of an outpatient clinic dedicated to the clinical immunology field in 1990 and head of the UIC – Unidade de Imunologia Clínica (Clinical Immunology Unit) of Centro Hospitalar Universitário do Porto (CHUP) since 2004 to 2016, when he retired from public functions; he is still working regularly pro bono in UIC.
He is Professor of Medicine at the Medical School Instituto Biomédicas Abel Salazar /CHUP, University of Porto.
He was coordinator of the hospital Infection Control Committee of CHUP of North Regional Administration and member of the National Committee against AIDS.
He is member of Euro-Lupus, of Euro-Phospholipid and of the international Lupus Nephritis Terminology Advisory Group, of the American College of Rheumatology since 1992, of the Portuguese Immunology Society since 1984, of the Portuguese Internal Medicine Society since 1985 and of the Consortium of Autoimmune Centers.
He and his team participated in international projects as BIOLUPUS, PreciseSADs, T2T in SLE and EULAR Lupus task force.
He participated in many congress committees in the field of clinical immunology and rheumatology; he was chair of the 8º European Lupus Meeting, Porto Abril 2011, and honorary president of the 11º Autoimmunity congress in Lisbon 2018.
He received the first National prize of the Portuguese Internal Medicine in 2016.
He is co-author of more than 140 publications in peer review international publications (H-index de 31).